NancyAnnParquetMD

PubMed

• What's Eating You? Tropical Rat Mite (Ornithonyssus bacoti).
  Rame Yousif, Madison Anzelc, Brandon Zakeri, Nancy Parquet> ;Cutis. 2023 Sep 1
• 64 citations
  Stemness of B cell progenitors in multiple myeloma bone marrow
  Kelly Boucher, Nancy Parquet, Raymond Widen, Kenneth H. Shain, Rachid Baz, Melissa Alsina, John M. Koomen, Claudio Anasetti, William S. Dalton, Lia Perez> ;Clinical Cancer Research. 2012 Nov 15
• 24 citations
  Bortezomib restores stroma-mediated APO2L/TRAIL apoptosis resistance in multiple myeloma.
  Lia Perez, Nancy Parquet, Mark B. Meads, Claudio Anasetti, William S. Dalton> ;European Journal of Haematology. 2010 Mar 1
• 12 citations
  SH2-inositol phosphatase 1 negatively influences early megakaryocyte progenitors.
  Lia Perez, Caroline Desponts, Nancy Parquet, William G. Kerr> ;Plos One. 2008 Oct 29
• 45 citations
  Bone marrow stroma confers resistance to Apo2 ligand/TRAIL in multiple myeloma in part by regulating c-FLIP.
  Lia Perez, Nancy Parquet, Kenneth H. Shain, Ramadevi Nimmanapalli, Melissa Alsina, Claudio Anasetti, William S. Dalton> ;Journal of Immunology. 2008 Feb 1
• 75 citations
  Tipifarnib and Bortezomib Are Synergistic and Overcome Cell Adhesion–Mediated Drug Resistance in Multiple Myeloma and Acute Myeloid Leukemia
  Niranjan Yanamandra, Nandita M. Colaco, Nancy Parquet, Robert W. Buzzeo, David Boulware, Gabriela Wright, Lia Perez, William S. Dalton, Darrin M. Beaupre> ;Clinical Cancer Research. 2006 Jan 15
• Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin''s lymphoma.
  Machover, D., Delmas-Marsalet, B., Misra, S. C., Gumus, Y., Goldschmidt, E., Schilf, A., Frénoy, N., Emile, J. F., Debuire, B., Guettier, C., Farrokhi, P., Boulefdaoui...> ;Ann Oncol. 2001 Oct
• Influence of CD34(+) marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia.
  Morariu-Zamfir R, Rocha V, Devergie A, Socié G, Ribaud P, Esperou H, Parquet N, Guardiola P, Dal Cortivo L, Bittencourt H, Garnier F, Traineau R, Marolleau JP, Chevret...> ;Bone Marrow Transplant.. 2001-03-01
• New oral formulation of cyclosporin A (Neoral) pharmacokinetics in allogeneic bone marrow transplant recipients.
  Parquet, N., Reigneau, O., Humbert, H., Guignard, M., Ribaud, P., Socié, G., Devergie, A., Espérou, H., Gluckman, E.> ;Bone Marrow Transplant. 2000 May
• Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients.
  Milpied N, Vasseur B, Parquet N, Garnier JL, Antoine C, Quartier P, Carret AS, Bouscary D, Faye A, Bourbigot B, Reguerre Y, Stoppa AM, Bourquard P, Hurault de Ligny B,...> ;Ann. Oncol.. 2000-01-01
• Fulminant adenovirus hepatitis after allogeneic bone marrow transplantation.
  Bertheau P, Parquet N, Ferchal F, Gluckman E, Brocheriou C> ;Bone Marrow Transplant.. 1996-02-01
• Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host di...
  Moussalem M, Esperou Bourdeau H, Devergie A, Baruchel A, Ribaud P, Socie G, Parquet N, Traineau R, Hirsch I, Schaison G> ;Bone Marrow Transplant.. 1995-06-01
• Join now to see all